| Issue |
Title |
| Vol 9, No 1 (2016) |
Use of Restasis (cyclosporine) in patients with dry eye syndrome |
|
|
Butin E.V., Florentseva S.S., Veselov A.V., Morozov M.A. |
| "... Dry eye syndrome produces an inflammatory process of autoimmune origin. Thus, the use ..." |
| Vol 9, No 1 (2016) |
Use of the drug in patients tealoz primary open angle glaucoma syndrome "dry eye" |
|
|
Ushakova L.I., Balalin S.V. |
| "... Dry eye syndrome is frequently observed in patients with primary open-angle glaucoma with prolonged ..." |
| Vol 9, No 4 (2016) |
Trehalose efficacy in dry eye syndrome treatment after phacoemulsification |
|
|
Astakhov S.Y., Tkachenko N.V. |
| "... to effectively fight against dry eye syndrome main signs and enhances treatment tolerance. ..." |
| Vol 7, No 4 (2014) |
The experience of “Hyloparin” use in clinical practice |
|
|
Tkachenko N.V., Astakhov S.Y. |
| "... The incidence of the “dry eye” syndrome diagnosis in developed countries increases from year ..." |
| Vol 6, No 1 (2013) |
Primenenie preparata Restasis® (RESTASIS®, tsiklosporin 0,05%) — glaznye kapli dlya lecheniya postgerpeticheskogo simblefarona |
|
|
Borisov D.A. |
| "... Borisov D. A.
G Key words: symblepharon; restasis; dry eye syn-
drome; herpetic keratoconjunctivitis ..." |
| Vol 10, No 2 (2017) |
Analysis of treatment results in dry eye syndrome patients after phacoemulsification by preservative-free 0.3% sodium hyaluronate eye drops |
|
|
Pirogov Y.I., Butina G.M., Oksentjuk A.A., Khromova E.S. |
| "... Postsurgical dry eye syndrome is found in a substantial proportion of patients after ..." |
| Vol 7, No 3 (2014) |
Current trends in the therapy of the ocular surface epithelial xerosis |
|
|
Brzheskaya I.V., Brjesky V.V., Radukhan M. |
| "... of the dry eye syndrome. In the article, the literature is summarized as to the agents used to treat the “dry ..." |
| Vol 8, No 2 (2015) |
Our experience of Restasis® use in patients with “dry eye” syndrome occurring against the context of graft versus host reaction after bone marrow allografting |
|
|
Astakhov S.Y., Tkachenko N.V., Chistyakova N.V. |
| "... -
тат против хозяина.
our experience of restasis® use in patients with “dry eye” syndrome
occurring ..." |
| Vol 6, No 2 (2013) |
Heidelberg Cornea Tomography usein assessment of Cyclosporin A treatmentresults in patients with “dry eye “ syndrome |
|
|
Florentseva S.S., Veselov A.V., Butin Y.V., Morozova N.V. |
| "... use
In assessment of CyClosporIn a treatment
results In patIents wIth “dry eye “ syndrome ..." |
| Vol 7, No 1 (2014) |
“Hylabak” and “Theagel” use for dry eye syndrome in diabetic patients |
|
|
Grigorieva N.N., Panfilova M.V., Stepanova E.N., Shadrichev F.E. |
| "... into consideration the role of metabolic impairments in the pathogenesis of diabetes and of dry eye syndrome ..." |
| Vol 7, No 1 (2014) |
The dry eye syndrome in patients treated for breast cancer and methods to correct it |
|
|
Kovalevskaya M.A., Turovets Y.K. |
| "... Treatment for breast cancer in women promotes the dry eye syndrome and its worsening during chemo ..." |
| Vol 7, No 1 (2014) |
The evolution of tear substitutes: from saline solutions to cationic nanoemulsion |
|
|
Vokhmyakov A.V. |
| "... eye drops versus Refresh® in
patients with mild to moderate dry eye syndrome. Eur J Ophthalmol
2011 ..." |
| Vol 7, No 1 (2014) |
Neurotrophic corneal and conjunctival xerosis |
|
|
Zhurova S.G. |
| "... patients (86 eyes) with severe dry eye syndrome complicated by xerotic corneal ulcers were examined. In all ..." |
| Vol 9, No 2 (2016) |
Trehalose efficacy in dry eye syndrome therapy in diabetic patients |
|
|
Grigorieva N.N., Peich M.E., Shadrichev F.E. |
| "... The prevalence of diabetes mellitus with ocular involvement and that of dry eye syndrome constantly ..." |
| Vol 11, No 1 (2018) |
Investigation of tear production dynamics in patients with age-related cataract before and after phacoemulsification |
|
|
Tonkonogiy S.V., Bai L.U., Vasilyev A.V. |
| "... with initial low TP indices have potentially high risk of developing clinically significant dry eye syndrome. ..." |
| Vol 6, No 4 (2013) |
The tolerability and clinical efficacy of “OKOMISTIN” in combination with “Oftalmoferon” in comparison to “Oftalmoferon” as monotherapy in the treatment of adenoviral eye diseases |
|
|
Astakhov Y.S., Sokolov V.O., Morozova N.V., Borisov D.A., Polovinkina G.V., Golikova Y.L., Botova N.V. |
| "... ” in comparison to “Oftalmoferon” as monotherapy in the treatment of adenoviral eye diseases. Material and methods ..." |
| Vol 7, No 2 (2014) |
Glaucoma and the dry eye syndrome |
|
|
Brjesky V.V., Radukhan M. |
| "... The development of the dry eye syndrome in glaucoma patients is a pressing challenge during last 10 ..." |
| Vol 10, No 3 (2017) |
Experience in the Cationorm® use in the treatment of dry eye syndrome in patients after adenoviral keratoconjunctivitis |
|
|
Sokolov V.O., Morozova N.V., Polovinkina G.V., Borisova M.L., Zvontsova I.N., Gasymzade L.M., Kulikova Y.A., Shtupun D.R., Batynkova O.S. |
| "... The dry eye syndrome ranges among widespread and persisting ophthalmic diseases. It is also called ..." |
| Vol 10, No 4 (2017) |
Experience in Gilan Comfort eye drops use of in patients after excimer laser surgery |
|
|
Astakhov S.Y., Riks I.A. |
| "... The article presents treatment results of the dry eye syndrome after excimer laser refractive ..." |
| Vol 9, No 3 (2016) |
Efficacy of 0.01% dexamethasone solution in comprehensive therapy of dry eye disease |
|
|
Brzheskiy V.V., Popov V.Y., Kalinina I.V., Kalinina N.M., Chenenova L.V. |
| "... antiinflammatory effect. But the widespread use of this dose in the management of dry eye diseases is limited ..." |
| Vol 10, No 1 (2017) |
Confocal microscopy in ocular surface disease |
|
|
Potemkin V.V., Varganova T.S., Ageeva E.V. |
| "... in patients with dry eye, and propose our examination algorithm of ocular surface investigation in dry eye ..." |
| Vol 10, No 4 (2017) |
Lacrimal system pathology in patients with malignant thyroid tumors after radioactive iodine therapy, and its correction methods |
|
|
Beldovskaya N.Y., Karpichenko S.A., Baranskaya S.V., Karpov A.A. |
| "... .8%) (among them, moderate dry eye syndrome was diagnosed in 3 cases); tear outflow pathology was revealed ..." |
| Vol 8, No 1 (2015) |
A comparative evaluation of antimicrobial eye drops cytotoxicity |
|
|
Aleksandrova O.I., Okolov I.N., Takhtaev Y.V., Khorolskaya J.I., Hintuba T.S., Blinova M.I. |
| "... cytotoxic effect of six antibacterial fluoroquinolone eye drops: 1. Cipromed™ (ciprofloxacin 0.3 %; Sentiss ..." |
| Vol 8, No 1 (2015) |
Congenital microphtalmos with cyst |
|
|
Gorbachev D.S., Korovenkov R.I. |
| "... considered.
G Key words: congenital microphthalmus; eye globe cyst.
G ОбзОры
УДК 617.7-007.21-053 ..." |
| Vol 8, No 2 (2015) |
Clinical case of congenital microphtalmos with cyst |
|
|
Gorbachev D.S., Korovenkov R.I. |
| "... be useful for practicing ophthalmologists.
G Key words: congenital microphthalmos; eye globe cyst ..." |
| Vol 10, No 1 (2017) |
Comparison of cytotoxicity of fluoroquinolone antimicrobial eye drops and its effect on their bioavailability |
|
|
Hintuba T.S., Takhtaev Y.V., Okolov I.N., Motyleva V.A., Shlyakman R.B. |
| "... eye drops, registered in the Russian Federation: 1) Oftaquix™ (levofloxacin 5 mg/ml; preservative ..." |
| Vol 6, No 4 (2013) |
Local cytokine status of experimental animalsat experimental intraocular implantationof titanium nickelide |
|
|
Steblyuk A.N., Kolesnikova N.V., Gyunter V.E. |
| "... Aleksey Nikolayevich — MD, PhD, ophthalmologist
S. N. Fyodorov Eye Microsurgery Complex, Krasnodar ..." |
| Vol 7, No 1 (2014) |
Microbial spectrum and microflora antibiotic sensitivity in patients with inflammatory eye diseases |
|
|
Borovskikh Y.V., Borobova I.M., Yegorov V.V. |
| "... The authors studied 1726 bacteriological cultures to find the etiology of inflammatory eye diseases ..." |
| Vol 9, No 1 (2016) |
On the problem of local antibiotic therapy in children with ocular surface diseases |
|
|
Fenkova O.G., Fursova A.Z., Gusarevich O.G. |
| "... . No side effects, including eye irritation, have been noted. Conclusion: topical Azithromycin ophthalmic ..." |
| Vol 8, No 4 (2015) |
A case of cosmetic rehabilitation after eyeball destruction (case report) |
|
|
Pysin A.Y., Kulikov A.N., Sosnovskiy S.V., Shamrey D.V. |
| "... rehabilitation indices after eyeball destruction.
G Key words: evisceration; open eye injury; eyeball ..." |
| Vol 9, No 2 (2016) |
Our experience of bromfenac-containing NSAID use in patients after cataract surgery |
|
|
Pirogov Y.I., Butina G.M., Morozov R.A., Oksentyuk A.A., Rybina M.V., Chshieva M.R., Shatalov M.S. |
| "... similar consumables had been performed in 792 patients (932 eyes). They were divided into three groups: 1 ..." |
| Vol 11, No 1 (2018) |
Influence of eye diseases on the mortality rate of the population |
|
|
Zolotarev A.V., Karlova E.V., Miroshnichenko E.V. |
| "... is an important problem of modern ophthalmology. Many researchers note that eye pathology, which leads to a visual ..." |
| Vol 10, No 3 (2017) |
Combination of congenital optic never coloboma in one eye and congenital choroidal coloboma in the fellow eye |
|
|
Simakova I.L., Kirillov Y.A., Sosnovskiy S.V., Tikhonovskay I.A., Kharakozov A.S., Nikolaenko E.N. |
| "... anomaly of both eyes manifesting itself by coloboma of the optic nerve head in the right eye and choroidal ..." |
| Vol 9, No 3 (2016) |
Pseudoexfoliation syndrome and ocular adnexa |
|
|
Potemkin V.V., Rakhmanov V.V., Ageeva E.V., Alchinova A.S., Meshveliani E.V. |
| "... Pseudoexfoliation syndrome (PEX) is a relatively widespread generalized age-related disease ..." |
| Vol 10, No 2 (2017) |
The influence of pseudoexfoliative syndrome on corneal morphology based on in vivo confocal microscopy |
|
|
Potemkin V.V., Varganova T.S., Akopov E.L., Ageeva E.V. |
| "... observed using confocal microscopy in patients with pseudoexfoliation (PEX) syndrome.
Methods: Overall ..." |
| Vol 9, No 2 (2016) |
Congenital capsular and zonular abnormalities |
|
|
Grabobetskiy V.R., Titarenko A.I., Papayan S.S. |
| "... .1.1.
31. Maumenee IH. The eye in the Marfan syndrome. Trans Am Oph-
thalmol Soc. 1981;79:684-733.
32 ..." |
| Vol 9, No 4 (2016) |
Pseudoexfoliation syndrome and meibomian gland dysfunction |
|
|
Potemkin V.V., Ageeva E.V. |
| "... syndrome and 128 eyes of 64 patients without it were enrolled in this prospective study. Results. The signs ..." |
| Vol 10, No 3 (2017) |
The influence of phacoemulsification on various corneal layers in patients with pseudoexfoliation syndrome assessed with confocal in vivo microscopy |
|
|
Potemkin V.V., Varganova T.S., Terekhova I.V., Ageeva E.V. |
| "... the impact of PHACO on corneal epithelium layers in patients with pseudoexfoliation syndrome (PEX ..." |
| Vol 11, No 2 (2018) |
Assessment of Corneal subbasal nerve plexus using confocal in vivo microscopy in patients with pseudoexfoliation syndrome after phacoemulsification |
|
|
Potyomkin V.V., Varganova T.S., Terehova I.V., Ageeva E.V. |
| "... of 24 patients (24 eyes) with PEX syndrome, and 18 patients (18 eyes) without it composed the control ..." |
| Vol 11, No 1 (2018) |
Zonular instability in patients with pseudoexfoliative syndrome: the analysis of 1000 consecutive phacoemulsifications |
|
|
Potyomkin V.V., Ageeva E.V. |
| "... Phacoemulsification (PHACO) is the gold standard of cataract surgery. Сataract surgery in eyes ..." |
| Vol 10, No 4 (2017) |
Wyburn-Mason syndrome |
|
|
Astakhov Y.S., Belekhova S.G., Shakhnazarova A.A., Ovnanyan A.Y. |
| "... of the Wyburn-Mason syndrome is presented. Etiology, pathogenesis, clinical picture, and diagnostic criteria ..." |
| Vol 7, No 3 (2014) |
Comparative analysis of vitreofoveolar traction syndrome surgical treatment |
|
|
Shkvorchenko D.O., Zakharov V.D., Rusanovskaya A.V., Belousova Y.V., Kakunina S.A., Mironova T.S., Pismenskaya V.A., Norman K.S. |
| "... This article focuses on the surgical treatment of the vitreomacular traction ( VMT) syndrome ..." |
| Vol 7, No 2 (2014) |
A clinical experience of atopic keratoconjunctivitis treatment |
|
|
Bakunina N.A. |
| "... regimen, based on immunomodulating Restasis® eye drops. ..." |
| Vol 6, No 4 (2013) |
Successful treatment of the Irvine-Gass syndrome with Nevanac |
|
|
Ro M.B., Ignatyev S.A., Alekseyev I.B., Korchuganova Y.A. |
| "... in the successful treatment of cystoid macular edema caused by cataract extraction (Irvine-Gass syndrome). ..." |
| Vol 7, No 4 (2014) |
Grönblad-Strandberg syndrome |
|
|
Timokhov V.L., Rusanovskaya A.V. |
| "... The Grönblad-Strandberg syndrome is an inherited disease characterized by mineralization of elastic ..." |
| Vol 6, No 1 (2013) |
The enzymatic vitreolysis — a new trend in the treatment of retinal vein occlusions |
|
|
Tultseva S.N. |
| "... vitreomacular adhesion and
risk of exudative age-related macular degeneration: paired eye study //
Am. J ..." |
| Vol 9, No 4 (2016) |
Superior orbital fissure syndrome caused by an internal carotid artery aneurysm in the cavernous sinus |
|
|
Astakhov Y.S., Marchenko O.A., Potemkin V.V., Titarenko A.I. |
| "... This article describes a case of superior orbital fissure syndrome caused by an internal carotid ..." |
| Vol 10, No 2 (2017) |
Enzymotherapy of toxic anterior segment syndrome after phacoemulsification |
|
|
Suvorov A.S., Sazhin T.G. |
| "... patients (123 eyes) with toxic anterior segment syndrome after phacoemulsification; patients of the group I ..." |
| Vol 11, No 2 (2018) |
Single step laser procedures combined technology in the treatment algorithm of advanced primary open-angle glaucoma stage after surgery |
|
|
Tumanyan E.R., Lyubimova T.S., Kozlova E.E., Shormaz I.N., Ivashchenko E.V. |
| "... stagewith high trabecular meshwork pigmentation in anterior chamber angle and pseudoexfoliation syndrome ..." |
| Vol 10, No 1 (2017) |
25-Hydroxyvitamin D and matrix metalloproteinases-2, -9 level in patients with primary open angle glaucoma and pseudoexfoliative glaucoma/syndrome |
|
|
Beletskaya I.S., Karonova T.L., Astakhov S.Y. |
| "... -angle glaucoma (POAG), pseudoexfoliation glaucoma (PEG), and pseudoexfoliation syndrome (PES ..." |
| 1 - 50 of 50 Items |
|
